UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________
FORM 6-K
_______________
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a(16) OR 15d(16) OF THE
SECURITIES EXCHANGE ACT OF 1934
January 16, 2001
CREO PRODUCTS INC.
(Exact name of Registrant as specified in
its charter)
3700 Gilmore Way
Burnaby, B.C. Canada V5G 4M1
(Address of principal executive offices)
(Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.)
Form 20-F [ X ]
Form 40-F
[ ]
(Indicate by check mark whether the registrant by
furnishing the information contained in this Form is also thereby
furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.)
Yes [ ]
No
[ X ]
FOR IMMEDIATE RELEASE
TIMING OF CREO PRODUCTS 2001 FIRST QUARTER EARNINGS
Vancouver, BC, CANADA (January 16, 2001) - Creo Products
Inc. (NASDAQ - CREO, TSE - CRE) announced that financial results for the 2001
first quarter are scheduled for release on Wednesday, February 7, 2001 at 4:30
pm ET.
The news release will also contain details of our conference call, which will
be held on Wednesday, February 7, 2001 at 5:00 pm ET. Investors will have an
opportunity to listen to the live web broadcast of the 2001 first quarter
earnings announcement by accessing the call at www.creo.com.
-###-
About Creo
Based in Vancouver, Canada, Creo
Products Inc. is a publicly held high-technology company focused on the
application of imaging and information technology. Through CreoScitex - its
principal operating division - Creo is leading the digital transformation of the
graphic arts industry. Creo Products Inc. trades under the symbols CREO on
NASDAQ and CRE on the Toronto Stock Exchange. www.creo.com
Creo, the Creo logo, CreoScitex, and the CreoScitex
logo, are registered trademarks or trademarks of Creo Products Inc. Other
products may be the registered trademarks or trademarks of their respective
companies.
Contact:
Tracy Rawa
Investor Relations
Vancouver, Canada
Tel: +1-604-451-27003
Email: [email protected]
